NEG+ Investor Data Room

Confidential — Authorized Access Only.
Sign in with your Microsoft account to continue.

Investor Certification & Confidentiality

Access to this data room is restricted to verified accredited investors subject to an executed Non-Disclosure Agreement with NEG+ Innovations, Inc. Unauthorized disclosure is strictly prohibited. These materials do not constitute an offer to sell or solicitation to buy securities. All offerings are made pursuant to Regulation D, Rule 506(b).
Step 1 — Accredited Investor Certification (Select one)
Step 2 — Non-Disclosure Agreement
Confidential — Authorized Personnel Only

NEG+ Innovations Investor Data Room

Submit Your Investment

To wire your investment into NEG+ Innovations, Inc., please request wire transfer instructions via email. Routing and account details are provided upon execution of the Subscription Agreement.

Company: NEG+ Innovations, Inc.
Bank: Mercury
Structure: Reg D Rule 506(b) — Accredited Investors Only

Wire instructions are transmitted securely via encrypted email following execution of your Subscription Agreement. Contact our investor relations team to begin the process.

Request Wire Instructions

Company Overview

Investor Pitch Deck

Full investor presentation — vision, market, pipeline, team, financials.

View Document
Executive Summary

Comprehensive investor overview — company, products, market, team, terms, and risks.

View Document
Company One-Pager

Single-page overview for quick reference and distribution.

View Document

Financial

Offering Memorandum

Reg D Rule 506(b) private placement memorandum.

View Document
5-Year Financial Model

Revenue projections, cost structure, and milestones.

View Document
Use of Proceeds

Detailed breakdown of capital allocation by category.

View Document
Cap Table

Current capitalization table and equity structure.

View Document

Clinical & Scientific

R&D Pipeline Overview

All four device programs — status, timeline, and milestones.

View Document
Device & IP Summary

Device descriptions and intellectual property summary.

View Document
IRB Submission — POP-Q AutoSense

IRB application and clinical trial design documentation.

View Document